Tower Research Capital (TRC)’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24K | Sell |
1,705
-1,766
| -51% | -$3.36K | ﹤0.01% | 4532 |
|
|
2025
Q1 | $5.07K | Buy |
3,471
+159
| +5% | +$232 | ﹤0.01% | 4165 |
|
|
2024
Q4 | $6.13K | Buy |
3,312
+1,307
| +65% | +$2.42K | ﹤0.01% | 4200 |
|
|
2024
Q3 | $4.75K | Sell |
2,005
-3,059
| -60% | -$7.25K | ﹤0.01% | 4433 |
|
|
2024
Q2 | $13.9K | Buy |
5,064
+3,367
| +198% | +$9.26K | ﹤0.01% | 3969 |
|
|
2024
Q1 | $7.09K | Sell |
1,697
-1,670
| -50% | -$6.98K | ﹤0.01% | 4261 |
|
|
2023
Q4 | $10.9K | Sell |
3,367
-2,210
| -40% | -$7.16K | ﹤0.01% | 4187 |
|
|
2023
Q3 | $16.7K | Buy |
5,577
+1,343
| +32% | +$4.03K | ﹤0.01% | 3535 |
|
|
2023
Q2 | $4.83K | Buy |
4,234
+1,091
| +35% | +$1.24K | ﹤0.01% | 4874 |
|
|
2023
Q1 | $5K | Sell |
3,143
-4,032
| -56% | -$6.41K | ﹤0.01% | 4927 |
|
|
2022
Q4 | $9K | Buy |
7,175
+6,271
| +694% | +$7.87K | ﹤0.01% | 4160 |
|
|
2022
Q3 | $4K | Sell |
904
-209
| -19% | -$925 | ﹤0.01% | 5222 |
|
|
2022
Q2 | $4K | Buy |
+1,113
| New | +$4K | ﹤0.01% | 5165 |
|
|
2021
Q4 | – | Sell |
-866
| Closed | -$3K | – | 6116 |
|
|
2021
Q3 | $3K | Buy |
866
+808
| +1,393% | +$2.8K | ﹤0.01% | 5074 |
|
|
2021
Q2 | $0 | Sell |
58
-928
| -94% | – | ﹤0.01% | 5450 |
|
|
2021
Q1 | $5K | Sell |
986
-3,688
| -79% | -$18.7K | ﹤0.01% | 4645 |
|
|
2020
Q4 | $14K | Buy |
4,674
+2,404
| +106% | +$7.2K | ﹤0.01% | 4085 |
|
|
2020
Q3 | $7K | Buy |
2,270
+173
| +8% | +$533 | ﹤0.01% | 4221 |
|
|
2020
Q2 | $8K | Buy |
+2,097
| New | +$8K | ﹤0.01% | 4093 |
|
|
2016
Q1 | – | Sell |
-3
| Closed | -$2K | – | 4078 |
|
|
2015
Q4 | $2K | Buy |
3
+1
| +50% | +$667 | ﹤0.01% | 3680 |
|
|
2015
Q3 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 3560 |
|